Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.2 USD | +2.85% | -4.97% | -30.75% |
Apr. 20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
Apr. 20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.75% | 4.12B | |
+68.11% | 62.86B | |
-0.97% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.04% | 26.46B | |
-22.52% | 18.9B | |
+4.70% | 12.67B | |
+23.78% | 12.27B | |
+27.95% | 12.07B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Wolfe Research Starts Immunovant With Outperform Rating, $55 Price Target